Performance of Plasma HSP90α, Serum EBV VCA IgA Antibody and Plasma EBV DNA for the Diagnosis and Prognosis Prediction of Nasopharyngeal Carcinoma

MLA

Zhaolei Cui, et al. “Performance of Plasma HSP90α, Serum EBV VCA IgA Antibody and Plasma EBV DNA for the Diagnosis and Prognosis Prediction of Nasopharyngeal Carcinoma.” Cancer Management and Research, vol. 13, July 2021, pp. 5793–802. EBSCOhost, https://doi.org/10.2147/cmar.s320541.

APA

Zhaolei Cui, Yansong Chen, Junying Guo, Qian Ye, & Yan Chen. (2021). Performance of Plasma HSP90α, Serum EBV VCA IgA Antibody and Plasma EBV DNA for the Diagnosis and Prognosis Prediction of Nasopharyngeal Carcinoma. Cancer Management and Research, 13, 5793–5802. https://doi.org/10.2147/cmar.s320541

Chicago

Zhaolei Cui, Yansong Chen, Junying Guo, Qian Ye, and Yan Chen. 2021. “Performance of Plasma HSP90α, Serum EBV VCA IgA Antibody and Plasma EBV DNA for the Diagnosis and Prognosis Prediction of Nasopharyngeal Carcinoma.” Cancer Management and Research 13 (July): 5793–5802. doi:10.2147/cmar.s320541.